All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer--a phase II study. (Q48493342)
Jump to navigation
Jump to search
scientific article published on 5 October 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer--a phase II study. |
scientific article published on 5 October 2014 |
Statements
1 reference
All-oral combination of lapatinib and capecitabine in patients with brain metastases from HER2-positive breast cancer--a phase II study. (English)
1 reference
Hanan Shawky
1 reference
Hesham Tawfik
1 reference
5 October 2014
1 reference
26
1 reference
4
1 reference
187-194
1 reference
Identifiers
1 reference
1 reference